Your browser doesn't support javascript.
loading
Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
Cherney, David Z I; Ferrannini, Ele; Umpierrez, Guillermo E; Peters, Anne L; Rosenstock, Julio; Powell, David R; Davies, Michael J; Banks, Phillip; Agarwal, Rajiv.
Affiliation
  • Cherney DZI; Division of Nephrology, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Ferrannini E; CNR Institute of Clinical Physiology, Pisa, Italy.
  • Umpierrez GE; Emory University, Atlanta, Georgia, USA.
  • Peters AL; Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
  • Rosenstock J; Velocity Clinical Research at Medical City, Dallas, Texas, USA.
  • Powell DR; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Davies MJ; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Banks P; Lexicon Pharmaceuticals, Inc., The Woodlands, Texas, USA.
  • Agarwal R; Indiana University School of Medicine, Richard L Roudebush VA Medical Center, Indianapolis, Indiana, USA.
Diabetes Obes Metab ; 25(6): 1646-1657, 2023 06.
Article in En | MEDLINE | ID: mdl-36782093
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Type: Article Affiliation country: Canada